REG

Cell Impact announces final outcome of the fully guaranteed rights issue

On December 23, 2021, Cell Impact AB (publ) (Nasdaq First North Growth Market: CI B) (“Cell Impact” or the “Company”) announced that the preliminary outcome for the rights issue (the “Rights Issue”), for which the subscription period ended on December 23, 2021, indicated that the Rights Issue was oversubscribed, which has now been confirmed by the final outcome. Thus, no guarantee commitments will be utilized. The Rights Issue will provide the Company with approximately SEK 349 million before deduction of transaction costs related to the Rights Issue.

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN CELL IMPACT AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW IN THIS DOCUMENT.

The Board of Directors in Cell Impact resolved on November 29, 2021, pursuant to the authorization granted by the extra general meeting on November 16, 2021, on a fully guaranteed rights issue of up to approximately SEK 349 million.

Final outcome

The Rights Issue is comprised of 16,812,094 series B shares, of which 15,984,144 series B shares, corresponding to approximately 95 percent of the offered series B shares, have been subscribed for with subscription rights. Additionally, applications for subscription of 11,975,933 series B shares without subscription rights, corresponding to approximately 71 percent of the offered series B shares, have been received. The Rights Issue is thus oversubscribed and no guarantee commitments will be utilized.

Notice of allotment

Those who have subscribed for series B shares without subscription rights will be allocated series B shares in accordance with the principles set out in the prospectus published on December 6, 2021. Notice of allotment to the persons who subscribed for series B shares without subscription rights is expected to be distributed on December 28, 2021. Subscribed and allotted series B shares shall be paid in cash within two banking days in accordance with the instructions on the settlement note sent to the subscriber. Subscribers who have subscribed through a nominee will receive notification of allocation in accordance with their respective nominee’s procedures. Only those who have been allotted shares will be notified.

Number of shares and share capital

Through the Rights Issue, Cell Impact’s share capital will increase by approximately SEK 1,946,103.3 to approximately SEK 8,757,465.5 and the number of series B shares will increase by 16,812,094 series B shares to 75,436,628 series B shares, which increases the total number of series A and B shares to 75,654,428 shares, when the Rights Issue has been registered with the Swedish Companies Registration Office. The last day of trading in paid subscribed shares (BTAs) is expected to be on January 4, 2022. The new series B shares subscribed for with and without subscription rights are expected to be traded on Nasdaq First North Growth Market as from January 11, 2022.

Advisers

In conjunction with the Rights Issue, the Company has engaged Carnegie Investment Bank AB (publ) as Sole Global Coordinator and Joint Bookrunner and Bryan, Garnier & Co as Joint Bookrunner. Advokatfirman Vinge and Advokatfirman Wåhlin AB act as legal advisers.

For more information, please contact:

Pär Teike, CEO, Cell Impact AB, +46 73-024 06 84 or [email protected].

About Cell Impact

Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell manufacturers. The company has developed and patented a unique method for high-velocity forming, Cell Impact Forming, which makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional forming methods.

The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company’s Certified Advisor (CA). Contact info: +46 8-528 00 399 or [email protected].

Important information

Publication, release, or distribution of this press release may in certain jurisdictions be subject to legal restrictions and persons in the jurisdictions where the press release has been made public or distributed should be informed of and follow such legal restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with applicable rules in each jurisdiction. This press release does not constitute an offer or solicitation to buy or subscribe for any securities in Cell Impact AB (publ) in any jurisdiction, either from Cell Impact AB (publ) or from anyone else.

This press release is not a prospectus according to the definition in Regulation (EU) 2017/2019 (the “Prospectus Regulation”) and has not been approved by any regulatory authority in any jurisdiction. A prospectus will be prepared by the Company and published on the Company’s website after the prospectus has been reviewed and approved by the Swedish Financial Supervisory Authority.

This press release does not constitute an offer or solicitation to buy or subscribe for securities in the United States. The securities mentioned herein may not be sold in the United States without registration, or without an exemption from registration, under the U.S. Securities Act from 1933 (“Securities Act”), and may not be offered or sold within the United States without being registered, covered by an exemption from, or part of a transaction that is not subject to the registration requirements according to the Securities Act. There is no intention to register any securities mentioned herein in the United States or to issue a public offering of such securities in the United States. The information in this press release may not be released, published, copied, reproduced or distributed, directly or indirectly, wholly or in part, in or to Australia, Hong Kong, Japan, Canada, New Zealand, Singapore, South Africa, the United States or any other jurisdiction where the release, publication or distribution of this information would violate current rules or where such an action is subject to legal restrictions or would require additional registration or other measures beyond those that follow from Swedish law. Actions in contravention of this instruction may constitute a violation of applicable securities legislation.

Forward-looking statements

This press release contains forward-looking statements related to the Company’s intentions, estimates or expectations with regard to the Company’s future results, financial position, liquidity, development, outlook, estimated growth, strategies and opportunities as well as the markets in which the Company is active. Forward-looking statements are statements that do not refer to historical facts and can be identified by the use of terms such as “believes”, “expects”, “anticipates”, “intends”, “estimates”, “will”, “may”, “implies”, “should”, “could” and, in each case, their negative, or comparable terminology. The forward-looking statements in this press release are based on various assumptions, which in several cases are based on further assumptions. Although the Company believes that the assumptions reflected in these forward-looking statements are reasonable, there is no guarantee that they will occur or that they are correct. Since these assumptions are based on assumptions or estimates and involve risks and uncertainties, actual results or outcomes, for many different reasons, may differ materially from those what is stated in the forward-looking statements. Due to such risks, uncertainties, eventualities and other significant factors, actual events may differ materially from the expectations that expressly or implicitly are contained in this press release through the forward-looking statements. The Company does not guarantee that the assumptions which serve as a basis for the forward-looking statements in this press release are correct, and each reader of the press release should not rely on the forward-looking statements in this press release. The information, opinions and forward-looking statements that expressly or implicitly are stated herein are provided only as of the date of this press release and may change. Neither the Company nor any other party will review, update, confirm or publicly announce any revision of any forward-looking statement to reflect events that occur or circumstances that arise with respect to the contents of this press release, beyond what is required by law or Nasdaq First North Growth Market Rulebook.

Potential investors should not put undue trust in the forward-looking statements herein, and potential investors are strongly recommended to read the sections in the prospectus that include a more detailed description of the factors that can affect the Company’s business and its associated market.

Om Cell Impact

Cell Impact AB (publ) är en global leverantör av avancerade flödesplattor och produktionsteknologi till tillverkare av bränsleceller med en unik metod för höghastighetsformning.

Bränsleceller omvandlar vätgas och syre till elektricitet och värme. Den enda restprodukten är vatten och därför utgör bränsleceller ett miljövänligt alternativ till både förbränningsmotorer och batterier.

Webbplats
www.cellimpact.com
Bransch
Industrivaror och -tjänster

Handelsinformation

Kurs ()
Förändring ()
Marknad Nasdaq First North Growth Market Kortnamn CI ISIN-kod SE0017885379 Certified Adviser FNCA